Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Penn-Nicholson

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 2, 2026
Bioequivalence of C-reactive protein in fingerprick blood and serum measured using the point-of-care LumiraDx test for tuberculosis diagnosis in exposed contactsArthur M Chiwaya, Shima M Abdulgader, Patricia Manjate, et al.
European Journal of Immunology|April 10, 2022
Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patientsStanley Kimbung Mbandi, Hannah Painter, Adam Penn-Nicholson, et al.
BMJ Global Health|May 11, 2026
User perspectives on the Molbio Truenat platform and tuberculosis assays for decentralised testing in Mozambique and TanzaniaMaria Del Mar Castro, Celso Khosa, Grace Mhalu, et al.
Nature|November 1, 2018
Author Correction: A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesRoshni Roy Chowdhury, Francesco Vallania, Qianting Yang, et al.
Frontiers in Immunology|March 15, 2021
Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young AdultsRichard Baguma, Stanley Kimbung Mbandi, Miguel J Rodo, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
Vaccine|June 15, 2015
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic settingAdam Penn-Nicholson, Hennie Geldenhuys, Wivine Burny, et al.
Nature|August 24, 2018
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesRoshni Roy Chowdhury, Francesco Vallania, Qianting Yang, et al.
The Journal of Infectious Diseases|May 6, 2024
Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in BrazilSimon C Mendelsohn, Bruno B Andrade, Stanley Kimbung Mbandi, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trialMichele Tameris, Helen Mearns, Adam Penn-Nicholson, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 2, 2026
Bioequivalence of C-reactive protein in fingerprick blood and serum measured using the point-of-care LumiraDx test for tuberculosis diagnosis in exposed contactsArthur M Chiwaya, Shima M Abdulgader, Patricia Manjate, et al.
European Journal of Immunology|April 10, 2022
Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patientsStanley Kimbung Mbandi, Hannah Painter, Adam Penn-Nicholson, et al.
BMJ Global Health|May 11, 2026
User perspectives on the Molbio Truenat platform and tuberculosis assays for decentralised testing in Mozambique and TanzaniaMaria Del Mar Castro, Celso Khosa, Grace Mhalu, et al.
Nature|November 1, 2018
Author Correction: A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesRoshni Roy Chowdhury, Francesco Vallania, Qianting Yang, et al.
Frontiers in Immunology|March 15, 2021
Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young AdultsRichard Baguma, Stanley Kimbung Mbandi, Miguel J Rodo, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
Vaccine|June 15, 2015
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic settingAdam Penn-Nicholson, Hennie Geldenhuys, Wivine Burny, et al.
Nature|August 24, 2018
A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomesRoshni Roy Chowdhury, Francesco Vallania, Qianting Yang, et al.
The Journal of Infectious Diseases|May 6, 2024
Transcriptomic Signatures of Progression to Tuberculosis Disease Among Close Contacts in BrazilSimon C Mendelsohn, Bruno B Andrade, Stanley Kimbung Mbandi, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trialMichele Tameris, Helen Mearns, Adam Penn-Nicholson, et al.
Pageof 10